Hongbo Wang

5PUBLICATIONS
14CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 10, 2026
Inhibition of PRMT5 triggers synthetic lethality in ARID1A-deficient endometrial cancer by promoting aberrant R-loop accumulation.

Wan Shu, Kejun Dong, Xiaoyu Shen

|Oct 11, 2024
The vasculogenic mimicry, CD146+ and CD105+ microvessel density in the prognosis of endometrioid endometrial adenocarcinoma: a single-centre immunohistochemical study.

Dmitry A Zinovkin, Hongbo Wang, Zhicheng Yu

|Oct 01, 2024
Integrating Bioinformatics and Experimental Validation to Identify Mitochondrial Permeability Transition-Driven Necrosis-Related lncRNAs that can Serve as Prognostic Biomarkers and Therapeutic Targets in Endometrial Carcinoma.

Ting Zhou, Haojia Li, Qi Zhang

|Jun 24, 2024
Bioinformatics Analysis and Experimental Verification Define Different Angiogenesis Subtypes in Endometrial Carcinoma and Identify a Prognostic Signature.

Qi Zhang, Yuwei Yao, Zhicheng Yu

|May 22, 2024
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway.

Rui Shi, Rong Zhao, Yan Shen

Pageof 1

Frequent Collaborators

1 joint publications

Dmitry A Zinovkin

1 joint publications

Zhicheng Yu

1 joint publications

Qian Zhang

1 joint publications

Yang Zhang